Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Al-Tourah, 2008, Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma, J Clin Oncol, 26, 5165, 10.1200/JCO.2008.16.0283
Bastion, 1997, Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients, J Clin Oncol, 15, 1587, 10.1200/JCO.1997.15.4.1587
Montoto, 2007, Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma, J Clin Oncol, 25, 2426, 10.1200/JCO.2006.09.3260
Conconi, 2012, Incidence, risk factors and outcome of histological transformation in follicular lymphoma, Br J Haematol, 157, 188, 10.1111/j.1365-2141.2012.09054.x
Gine, 2006, The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma, Ann Oncol, 17, 1539, 10.1093/annonc/mdl162
Horning, 1993, Natural history of and therapy for the indolent non-Hodgkin's lymphomas, Semin Oncol, 20, 75
Yuen, 1995, Long-term survival after histologic transformation of low-grade follicular lymphoma, J Clin Oncol, 13, 1726, 10.1200/JCO.1995.13.7.1726
Eide, 2011, High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study, Br J Haematol, 152, 600, 10.1111/j.1365-2141.2010.08519.x
Chen, 2001, Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma, Br J Haematol, 113, 202, 10.1046/j.1365-2141.2001.02705.x
Williams, 2001, High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry, J Clin Oncol, 19, 727, 10.1200/JCO.2001.19.3.727
Ramadan, 2008, Autologous stem cell transplantation is superior to myeloablative allogeneic SCT as a salvage therapy for patients with refractory/relapsed transformed lymphoma, Blood, 112, 4459, 10.1182/blood.V112.11.4459.4459
Sabloff, 2007, A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma, Biol Blood Marrow Transplant, 13, 956, 10.1016/j.bbmt.2007.04.009
Friedberg, 1999, Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies, Biol Blood Marrow Transplant, 5, 262, 10.1053/bbmt.1999.v5.pm10465106
Foran, 1998, High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre, Ann Oncol, 9, 865, 10.1023/A:1008349427337
Andreadis, 2005, Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma, Bone Marrow Transplant, 36, 955, 10.1038/sj.bmt.1705178
Ban-Hoefen, 2012, High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era, Leuk Lymphoma, 53, 830, 10.3109/10428194.2011.631637
Villa, 2011, Autologous and allogeneic stem cell transplantation for transformed indolent non-Hodgkin lymphoma: a report of the Canadian Blood and Marrow Transplant Group (CBMTG), Ann Oncol, 22, iv115
Herold, 2007, Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: an East German Study Group Hematology and Oncology Study, J Clin Oncol, 25, 1986, 10.1200/JCO.2006.06.4618
Marcus, 2005, CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma, Blood, 105, 1417, 10.1182/blood-2004-08-3175
Salles, 2008, Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study, Blood, 112, 4824, 10.1182/blood-2008-04-153189
Salles, 2011, Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial, Lancet, 377, 42, 10.1016/S0140-6736(10)62175-7
van Oers, 2010, Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study, J Clin Oncol, 28, 2853, 10.1200/JCO.2009.26.5827
Feugier, 2005, Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte, J Clin Oncol, 23, 4117, 10.1200/JCO.2005.09.131
Habermann, 2006, Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma, J Clin Oncol, 24, 3121, 10.1200/JCO.2005.05.1003
Pfreundschuh, 2008, Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), Lancet Oncol, 9, 105, 10.1016/S1470-2045(08)70002-0
Pfreundschuh, 2006, CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group, Lancet Oncol, 7, 379, 10.1016/S1470-2045(06)70664-7
Tan, 2008, Improved prognosis after histologic transformation (HT) of follicular lymphoma: the Stanford experience 1960–2003, Ann Oncol, 19, iv111
Al-Tourah, 2007, Addition of rituximab to CHOP chemotherapy significantly improves survival of patients with transformed lymphoma, Blood, 110, 790, 10.1182/blood.V110.11.790.790
Cheson, 1999, Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, J Clin Oncol, 17, 1244, 10.1200/JCO.1999.17.4.1244
Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452
Bains, 2013, Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy, Ann Oncol, 24, 428, 10.1093/annonc/mds433
Vellenga, 2008, Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial, Blood, 111, 537, 10.1182/blood-2007-08-108415